Metabolic & Weight
Tirzepatide
A dual GIP/GLP-1 receptor agonist that has reshaped metabolic research, widely studied for weight management and glucose control.
What it is
Tirzepatide is a dual agonist that activates both the GIP and GLP-1 receptors. It's one of the most extensively studied compounds in modern metabolic medicine.
How it's thought to work
By engaging two incretin pathways simultaneously, tirzepatide slows gastric emptying, increases satiety and improves how the body manages blood sugar. The combined GIP + GLP-1 action appears to be more effective than GLP-1 alone.
Potential health benefits
Researched for:
- Significant, sustained weight reduction.
- Improved glycaemic (blood-sugar) control.
- Reduced appetite and food intake.
What the research says
Tirzepatide has strong, large-scale human clinical evidence behind its metabolic effects and is among the best-documented compounds in this category. Common reported effects in trials are gastrointestinal (nausea), usually easing over time.
Considerations
Sold as a research compound. It meaningfully affects appetite and digestion; use should be under qualified medical supervision.
Recommended suppliers
Where to find research-grade Tirzepatide
If you're sourcing Tirzepatide for research, we recommend Pharma Tides— independently tested, >99% HPLC purity, with a Certificate of Analysis on every batch.
View Tirzepatide at Pharma Tides